EVOLUS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.93 USD | +1.77% |
|
+1.49% | +3.80% |
Chart calendar Evolus, Inc.
6ee9ea6f.53kcofeZ2IL8j29m0SQehlPVz_vrTij_jmcXbU7Zle8.pkpq5J2r6tTMvz1SiX117z2x-cq7Kh-LzBJHJSS9zYehEF7QwfOptLDhVw~d8aac72d0dec42d015427cb2e5ce46ec
Upcoming events on Evolus, Inc.
Past events on Evolus, Inc.
| 06/06/2024 16:00 | Annual General Meeting |
| 07/05/2024 21:30 | Q1 2024 Earnings Call |
| 07/05/2024 21:05 | Q1 2024 Earnings Release |
| 09/04/2024 14:30 | Needham Healthcare Conference - Fireside Chat |
| 13/03/2024 12:00 | Barclays Global Healthcare Conference |
| 12/03/2024 14:00 | Leerink Partners Global Biopharma Conference |
| 07/03/2024 21:30 | Q4 2023 Earnings Call |
| 07/03/2024 21:05 | Q4 2023 Earnings Release |
| 28/11/2023 15:00 | Evercore ISI HealthCONx Conference |
| 15/11/2023 16:30 | Stifel Healthcare Conference |
| 07/11/2023 21:30 | Q3 2023 Earnings Call |
| 07/11/2023 21:16 | Q3 2023 Earnings Release |
| 03/11/2023 21:30 | American Society for Dermatologic Surgery Meeting |
| 26/09/2023 14:20 | Cantor Global Healthcare Conference |
| 12/09/2023 16:00 | H.C. Wainwright Global Investment Conference |
| 09/08/2023 13:30 | Canaccord Genuity Growth Conference |
| 02/08/2023 21:30 | Q2 2023 Earnings Call |
| 02/08/2023 21:05 | Q2 2023 Earnings Release |
| 09/06/2023 16:00 | Annual General Meeting |
| 23/05/2023 16:00 | BNP Paribas Exane Aesthetics Day |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 34,9 34,5 1.24% | 56,5 56,7 -0.27% | 99,7 99,8 -0.09% | 149 149 -0.21% | 202 202 -0.03% | 262 |
|
EBITDA Million USD | Released Forecast Spread | -94,8 -87,0 -9.01% | -54,0 -44,4 -21.84% | -42,8 -44,1 2.96% | -43,0 -56,0 23.18% | -23,4 -27,7 15.57% | 0,98 |
|
EBIT Million USD | Released Forecast Spread | -98,9 -107 7.75% | -153 -52,5 -191.4% | -44,4 -52,5 15.48% | -65,3 -59,9 -9.12% | -49,2 -48,9 -0.58% | -22,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -105 -118 11.29% | -163 -63,7 -155.65% | -46,8 -55,1 15.17% | -74,3 -72,1 -3.03% | -61,5 -61,3 -0.35% | -39,9 |
|
Net income Million USD | Released Forecast Spread | -90,0 -108 17.01% | -163 -63,2 -157.8% | -46,8 -52,3 10.42% | -74,4 -73,3 -1.51% | -61,7 -61,4 -0.48% | -44,5 |
|
EPS USD | Released Forecast Spread | -3,19 -3,68 13.37% | -4,83 -1,87 -158.01% | -0,94 -0,93 -1.08% | -1,33 -1,31 -1.66% | -1,08 -1,08 -0.31% | -0,69 |
| Announcement Date | 25/02/20 | 24/03/21 | 03/03/22 | 08/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 33,9 29,8 13.68% | 37,2 36,6 1.41% | 33,9 36,0 -5.89% | 43,6 43,8 -0.4% | 41,7 40,5 2.97% | 49,3 49,2 0.4% | 50,0 44,4 12.72% | 61,0 61,1 -0.09% | 59,3 57,3 3.51% | 65,2 | 62,4 | 76,2 | 74,8 | 81,3 |
|
EBITDA Million USD | Released Forecast Spread | -14,5 -15,2 4.43% | -14,1 -13,1 -7.88% | -13,3 -14,8 10.37% | -5,39 | -5,90 -5,69 -3.55% | -8,02 -9,97 19.6% | -5,73 -10,2 43.81% | -3,74 1,25 -399.2% | -0,86 -0,62 -37.18% | 1,92 | -4,34 | 4,26 | ||
|
EBIT Million USD | Released Forecast Spread | -15,4 -26,0 40.57% | -21,3 -14,8 -44.43% | -17,9 -16,9 -6% | -10,6 -8,95 -18.86% | -12,0 -10,7 -12.56% | -15,1 -12,8 -18.2% | -13,4 -13,8 2.84% | -8,64 -8,00 -7.99% | -8,92 -7,81 -14.19% | -5,56 | -5,36 | -0,08 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,5 -27,7 36.75% | -23,4 -16,6 -41.56% | -20,3 -18,9 -7.39% | -13,1 -11,0 -19.42% | -14,8 -14,4 -2.28% | -18,1 -16,1 -12.27% | -16,9 -16,8 -0.48% | -11,7 -11,5 -1.96% | -13,1 -11,4 -14.58% | -9,65 | -9,45 | -4,17 | ||
|
Net income Million USD | Released Forecast Spread | -17,4 -25,7 32.43% | -23,5 -16,5 -42.29% | -20,3 -19,8 -2.52% | -13,2 -12,1 -9.01% | -14,8 -14,3 -3.58% | -18,1 -17,8 -2.18% | -16,9 -17,1 0.97% | -11,8 -12,2 2.82% | -13,1 -12,5 -4.46% | -10,3 | -10,9 | -6,01 | ||
|
EPS USD | Released Forecast Spread | -0,31 -0,44 28.74% | -0,42 -0,31 -35.48% | -0,36 -0,36 0% | -0,23 -0,22 -6.98% | -0,26 -0,25 -3.17% | -0,32 -0,32 -1.59% | -0,30 -0,29 -2.74% | -0,20 -0,22 6.98% | -0,22 -0,22 -1.15% | -0,17 | -0,18 | -0,08 | ||
| Announcement Date | 10/05/22 | 02/08/22 | 08/11/22 | 08/03/23 | 09/05/23 | 02/08/23 | 07/11/23 | 07/03/24 | 07/05/24 | - | - | - | - | - |
More events
Past sector events for Evolus, Inc.
| 21/06/2024 16:28 | DEVA HOLDING: Q1 2024 Earnings Release |
| 13/06/2024 22:21 | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
| 11/06/2024 06:30 | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
| 07/06/2024 11:33 | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
| 07/06/2024 10:17 | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
| 30/05/2024 13:08 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 30/05/2024 12:00 | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 30/05/2024 07:24 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 13:00 | FDC LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 10:26 | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EOLS Stock
- Calendar Evolus, Inc.
